Articles Published in 2009

Quotient Acquires GE’s Radio-labeling Business, Plans $24M Facility

Monday, July 13, 2009 07:00 AM

UK-based Quotient Bioresearch recently acquired Amersham Radiolabeling Service, the radiochemical synthesis operations of GE Healthcare, and plans to invest up to 15 million pounds ($24 million) in a state-of-the-art radiochemicals facility.

More... »

MPI Research Opens First Indian Office

Friday, July 10, 2009 08:43 AM

MPI Research recently opened an office in Ahmedabad, India--the CRO's first location in India. Up until now, MPI has served the Indian clinical research market through its U.S. headquarters in Mattawan, Mich.

More... »

ICON Acquires Veeda Laboratories

Thursday, July 9, 2009 08:03 AM

Dublin, Ireland-based contract research organization ICON acquired Veeda Laboratories, a provider of biomarker laboratory services for an undisclosed sum.

More... »

Chiltern Opens Hungary Office

Wednesday, July 8, 2009 07:23 AM

UK-based contract research organization (CRO) Chiltern International opened a new office in Budapest, Hungary.

More... »

OmniComm Buys EDC Business, Looks for Other Acquisitions

Tuesday, July 7, 2009 07:00 AM

EClinical provider OmniComm Systems recently acquired eResearch Technology's (ERT) electronic data capture (EDC) business in a move that OmniComm executives hope will help the Fort Lauderdale, Fla.-based company become a top-tier EDC provider.

More... »

ICREL Survey Findings Reveal Need for EU CT Directive Changes

Thursday, July 2, 2009 08:00 AM

Multinational trials have become increasingly complex and timelines have lengthened since the European Union Clinical Trial Directive 2001/20/EC went into effect. This has resulted in stakeholders' need for more staff and ultimately higher costs to run drug development programs in Europe. While stakeholders have anecdotally drawn similar conclusions, a report by The Impact on Clinical Research of European Legislation (ICREL), is now able to provide hard data to back up these claims. The report demonstrates the significant impact of the directive on all stakeholders.

More... »

CenterWatch Monthly July 2009

Wednesday, July 1, 2009 07:00 AM

China Ushers In New Era of Innovation

More... »

Medidata Raises $88 Million in IPO

Monday, June 29, 2009 11:26 AM

Medidata Solutions priced its initial public offering last Thursday, following weeks of speculation over when the clinical trial software company might go public. Medidata raised $88.2 million on the NASDAQ exchange with 6.3 million shares of common stock priced at $14 a share, above its initial range of $11 to $13.

Medidata reported revenue of $105.7 million for 2008 compared with $63 million in 2007. Since its founding in 1999, Medidata has been unprofitable until its most recent quarter ended March 31, when it reported $1.7 million in net income.

Shares of Medidata Solutions rose as much as 36% to $19 in its first day of trading June 25. At press time today, shares had fallen back to $16.25 a share, still well above its pricing.

The company is trading under the symbol MDSO. 

Citi and Credit Suisse Securities acted as joint managers for the offering. Jefferies & Company and Needham & Company were co-managers.

More... »

Excel Life Sciences and PFC Pharma Focus Open CRO in India

Monday, June 29, 2009 07:00 AM

Indian site management organization Excel Life Sciences (ELS) and Swiss contract research organization (CRO) PFC Pharma Focus (PFC) have formed an exclusive partnership to launch a new CRO in India.

More... »

Dedicated Phase I Appoints New CMO

Friday, June 26, 2009 10:54 AM

Dedicated Phase I in Phoenix, Ariz., named a new chief medical officer to head its 80-bed phase I clinical research facility. Clark Springgate, M.D., Ph.D., brings more than 25 years' experience to the organization, having directed and participated in more than 256 clinical trials, including first-in-man and first-in-therapeutic-class studies.

More... »